- Home
- SLS vs IMOS Comparison
SLS vs IMOS Comparison
Compare SLS & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | IMOS |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 2007 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SLS | IMOS |
|---|---|---|
| Price | $11.28 | $72.67 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $32.50 | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 61.6K |
| Earning Date | 11-11-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.61 |
| Revenue Next Year | N/A | $18.30 |
| P/E Ratio | ★ N/A | $158.35 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $19.24 |
| 52 Week High | $15.88 | $78.35 |
Technical Indicators
Market Signals| Indicator | SLS | IMOS |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 66.96 |
| Support Level | $10.82 | $53.64 |
| Resistance Level | $15.77 | $71.95 |
| Average True Range (ATR) | 0.75 | 1.65 |
| MACD | 0.02 | 1.16 |
| Stochastic Oscillator | 79.10 | 93.32 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.